GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $13,000 | +30.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | -37.5% | 200 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $16,000 | +77.8% | 200 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $9,000 | -18.2% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | 0.0% | 200 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $11,000 | +37.5% | 200 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $8,000 | -46.7% | 200 | -50.0% | 0.00% | -50.0% |
| Q3 2018 | $15,000 | -53.1% | 400 | -42.9% | 0.00% | -50.0% |
| Q2 2018 | $32,000 | +220.0% | 700 | +250.0% | 0.01% | +166.7% |
| Q1 2018 | $10,000 | -64.3% | 200 | -71.4% | 0.00% | -62.5% |
| Q4 2017 | $28,000 | +21.7% | 700 | -8.5% | 0.01% | +14.3% |
| Q3 2017 | $23,000 | +155.6% | 765 | +131.8% | 0.01% | +133.3% |
| Q2 2017 | $9,000 | -25.0% | 330 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $12,000 | – | 330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |